Trinity Biotech ADR buy StockNews.com
Start price
30.04.23
/
50%
€0.96
Target price
30.04.24
-
Performance (%)
-56.86%
End price
01.05.24
-
Summary
This prediction is currently being closed. Massive losses of -56.86% have been the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Trinity Biotech ADR, but this time predicts that Trinity Biotech ADR is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Trinity Biotech ADR | - | - | - |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten